Literature DB >> 10786701

Aggregated beta amyloid peptide 1-40 decreases Ca2+- and cholinergic receptor-mediated phosphoinositide degradation by alteration of membrane and cytosolic phospholipase C in brain cortex.

A Zambrzycka1, R P Strosznajder, J B Strosznajder.   

Abstract

The effects of full-length amyloid beta protein, A(beta) (1-40), on phosphoinositide-specific phospholipase C (PLC) were investigated in synaptic plasma membranes (SPM) and cytosol prepared from the cerebral cortex of adult rats. Moreover, the role of A(beta) (1-40) on the activation of lipid peroxidation was evaluated. The activity of phospholipase C (PLC) acting on phosphatidylinositol (PI) and phosphatidylinositol-4,5-bisphosphate (PIP2) was determined using exogenous labeled substrates. The subcellular fractions were the source of enzyme(s). The radioactivity of lipid messengers derived from degradation of [14C- arachidonoyl] PI was also determined. The stable aggregated form of beta-amyloid peptide (1-40) at 25 microM concentration exerted reproducible effects. The aggregated form of A(beta) (1-40) inhibited Ca(2+)-regulated PI and PIP2 degradation by SPM and cytosolic enzymes. Aggregated A(beta) also decreased significantly the level of diacylglycerol, the product of PLC. This additionally supports the inhibitory effect of A(beta) on membrane-bound and cytosolic PLC. Moreover, A(beta) (1-40) significantly decreased the basal activity of the PIP2-PLC in SPM and the enzyme activity regulated through cholinergic receptors. However, in spite of the lower enzyme activity, the percentage distribution of inositol (1,4,5) P3 radioactivity (IP3) in the total pool of inositol metabolites was not significantly changed. The aggregated neurotoxic fragment, A(beta) (25-35), mimicked the effect of full-length A(beta) (1-40). A(beta) (1-40) enhanced the level of malondialdehyde indicating an activation of free radical stimulated membrane lipid peroxidation that may be involved in alteration of phospholipase(s) activity. Our results indicated that aggregated A(beta) (1-40) alters Ca(2+)-dependent phosphoinositide degradation affecting synaptic plasma membrane and cytosolic phospholipase(s) activity. Moreover, this peptide significantly decreased the phosphoinositide-dependent signal transduction mediated by cholinergic receptors. The effect of aggregated A(beta) (1-40) is more pronounced than that of the neurotoxic fragment A(beta) (25-35). Our study suggests that the deposition of aggregated A(beta) may alter phosphoinositide signaling in brain.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10786701     DOI: 10.1023/a:1007511217525

Source DB:  PubMed          Journal:  Neurochem Res        ISSN: 0364-3190            Impact factor:   3.996


  34 in total

1.  Beta-amyloid neurotoxicity in vitro: evidence of oxidative stress but not protection by antioxidants.

Authors:  C J Pike; N Ramezan-Arab; C W Cotman
Journal:  J Neurochem       Date:  1997-10       Impact factor: 5.372

2.  Amyloid beta protein (25-35) stimulation of phospholipase C in LA-N-2 cells.

Authors:  I N Singh; G Sorrentino; J N Kanfer
Journal:  J Neurochem       Date:  1997-07       Impact factor: 5.372

Review 3.  Mechanisms of neuronal degeneration in Alzheimer's disease.

Authors:  B A Yankner
Journal:  Neuron       Date:  1996-05       Impact factor: 17.173

4.  Fusogenic properties of the C-terminal domain of the Alzheimer beta-amyloid peptide.

Authors:  T Pillot; M Goethals; B Vanloo; C Talussot; R Brasseur; J Vandekerckhove; M Rosseneu; L Lins
Journal:  J Biol Chem       Date:  1996-11-15       Impact factor: 5.157

5.  Predicting the in vitro toxicity of synthetic beta-amyloid (1-40).

Authors:  S K Brining
Journal:  Neurobiol Aging       Date:  1997 Nov-Dec       Impact factor: 4.673

6.  Isolation of low-molecular-weight proteins from amyloid plaque fibers in Alzheimer's disease.

Authors:  D J Selkoe; C R Abraham; M B Podlisny; L K Duffy
Journal:  J Neurochem       Date:  1986-06       Impact factor: 5.372

7.  Calcium ionophore increases amyloid beta peptide production by cultured cells.

Authors:  H W Querfurth; D J Selkoe
Journal:  Biochemistry       Date:  1994-04-19       Impact factor: 3.162

8.  beta-Amyloid polypeptide increases calcium-uptake in PC12 cells: a possible mechanism for its cellular toxicity in Alzheimer's disease.

Authors:  R Fukuyama; K C Wadhwani; Z Galdzicki; S I Rapoport; G Ehrenstein
Journal:  Brain Res       Date:  1994-12-26       Impact factor: 3.252

9.  Production of the Alzheimer amyloid beta protein by normal proteolytic processing.

Authors:  M Shoji; T E Golde; J Ghiso; T T Cheung; S Estus; L M Shaffer; X D Cai; D M McKay; R Tintner; B Frangione
Journal:  Science       Date:  1992-10-02       Impact factor: 47.728

10.  Amyloid beta protein (25-35) stimulation of phospholipases A, C and D activities of LA-N-2 cells.

Authors:  I N Singh; D G McCartney; J N Kanfer
Journal:  FEBS Lett       Date:  1995-05-29       Impact factor: 4.124

View more
  3 in total

1.  Effects of aging and amyloid-beta peptides on choline acetyltransferase activity in rat brain.

Authors:  Agata Zambrzycka; Mario Alberghina; Joanna B Strosznajder
Journal:  Neurochem Res       Date:  2002-04       Impact factor: 3.996

2.  Changes of enzyme activity in lipid signaling pathways related to substrate reordering.

Authors:  Dino G Salinas; Milton De La Fuente; Juan G Reyes
Journal:  Biophys J       Date:  2005-05-13       Impact factor: 4.033

Review 3.  TRPM7 and its role in neurodegenerative diseases.

Authors:  Yuyang Sun; Pramod Sukumaran; Anne Schaar; Brij B Singh
Journal:  Channels (Austin)       Date:  2015-07-28       Impact factor: 2.581

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.